Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schermer

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Alcoholism, Clinical and Experimental Research|January 31, 2006
Addressing substance abuse in health care settingsWilliam R Miller, Catherine Baca, Wilson M Compton, et al.
Journal of Managed Care & Specialty Pharmacy|December 28, 2016
Impact of Overactive Bladder Step Therapy Policies on Medication Utilization and Expenditures Among Treated Medicare MembersIbrahim M Abbass, Eleanor O Caplan, Daniel B Ng, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 24, 2018
Validation of ACCESS: an automated tool to support self-management of COPD exacerbationsLonneke M Boer, Maarten van der Heijden, Nathalie Me van Kuijk, et al.
NPJ Primary Care Respiratory Medicine|April 24, 2015
Exploring the impact of chronic obstructive pulmonary disease (COPD) on diabetes control in diabetes patients: a prospective observational study in general practiceHilde D Luijks, Wim J C de Grauw, Jacobus H J Bor, et al.
The Journal of Urology|January 3, 2020
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)Steven A Kaplan, Sender Herschorn, Kevin T McVary, et al.
International Archives of Occupational and Environmental Health|May 17, 2005
Employment status and quality of life in patients with chronic obstructive pulmonary diseaseKarin H Orbon, Tjard R Schermer, Joost W van der Gulden, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|August 13, 2008
Adverse clinical outcomes associated with elevated blood alcohol levels at the time of burn injuryGeoffrey M Silver, Joslyn M Albright, Carol R Schermer, et al.
BMC Pulmonary Medicine|March 24, 2012
Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjectsReinier P Akkermans, Marvin A Berrevoets, Ivo J Smeele, et al.
Family Practice|May 23, 2018
Is the plasma aldosterone-to-renin ratio associated with blood pressure response to treatment in general practice?Sabine C Käyser, Bianca W M Schalk, Wim J C de Grauw, et al.
Contemporary Clinical Trials|May 20, 2018
A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodologyEric S Rovner, Kevin V Carlson, Anna S Deal, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Alcoholism, Clinical and Experimental Research|January 31, 2006
Addressing substance abuse in health care settingsWilliam R Miller, Catherine Baca, Wilson M Compton, et al.
Journal of Managed Care & Specialty Pharmacy|December 28, 2016
Impact of Overactive Bladder Step Therapy Policies on Medication Utilization and Expenditures Among Treated Medicare MembersIbrahim M Abbass, Eleanor O Caplan, Daniel B Ng, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 24, 2018
Validation of ACCESS: an automated tool to support self-management of COPD exacerbationsLonneke M Boer, Maarten van der Heijden, Nathalie Me van Kuijk, et al.
NPJ Primary Care Respiratory Medicine|April 24, 2015
Exploring the impact of chronic obstructive pulmonary disease (COPD) on diabetes control in diabetes patients: a prospective observational study in general practiceHilde D Luijks, Wim J C de Grauw, Jacobus H J Bor, et al.
The Journal of Urology|January 3, 2020
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)Steven A Kaplan, Sender Herschorn, Kevin T McVary, et al.
International Archives of Occupational and Environmental Health|May 17, 2005
Employment status and quality of life in patients with chronic obstructive pulmonary diseaseKarin H Orbon, Tjard R Schermer, Joost W van der Gulden, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|August 13, 2008
Adverse clinical outcomes associated with elevated blood alcohol levels at the time of burn injuryGeoffrey M Silver, Joslyn M Albright, Carol R Schermer, et al.
BMC Pulmonary Medicine|March 24, 2012
Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjectsReinier P Akkermans, Marvin A Berrevoets, Ivo J Smeele, et al.
Family Practice|May 23, 2018
Is the plasma aldosterone-to-renin ratio associated with blood pressure response to treatment in general practice?Sabine C Käyser, Bianca W M Schalk, Wim J C de Grauw, et al.
Contemporary Clinical Trials|May 20, 2018
A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodologyEric S Rovner, Kevin V Carlson, Anna S Deal, et al.
Pageof 13